(S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y): A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine Receptors
- 1 January 1996
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (17), 3235-3237
- https://doi.org/10.1021/jm960328w
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5Neuropharmacology, 1995
- Diversity and Patterns of Regulation of Nicotinic Receptor SubtypesaAnnals of the New York Academy of Sciences, 1995
- Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's DiseaseCNS Drug Reviews, 1995
- Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neuronsLife Sciences, 1994
- Allosteric modulations of the nicotinic acetylcholine receptorTrends in Neurosciences, 1993
- The Diversity of Neuronal Nicotinic Acetylcholine ReceptorsAnnual Review of Neuroscience, 1993
- Characterization of l‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the NormalJournal of Neurochemistry, 1986
- Synthesis of arylacetylenes by the sodium hydride catalyzed cleavage of 4-aryl-2-methyl-3-butyn-2-olsThe Journal of Organic Chemistry, 1985
- Resolution of (.+-.)-5-bromonornicotine. Synthesis of (R)- and (S)-nornicotine of high enantiomeric purityThe Journal of Organic Chemistry, 1982
- Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine systemBrain Research, 1970